» Articles » PMID: 35055103

The Role of Estriol and Estrone in Keratoconic Stromal Sex Hormone Receptors

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 21
PMID 35055103
Authors
Affiliations
Soon will be listed here.
Abstract

Keratoconus (KC) is a progressive corneal thinning disease that manifests in puberty and worsens during pregnancy. KC onset and progression are attributed to diverse factors that include: environmental, genetics, and hormonal imbalances; however, the pathobiology remains elusive. This study aims to determine the role of corneal stroma sex hormone receptors in KC and their interplay with estrone (E1) and estriol (E3) using our established 3D in vitro model. Healthy cornea stromal cells (HCFs) and KC cornea stromal cells (HKCs), both male and female, were stimulated with various concentrations of E1 and E3. Significant changes were observed between cell types, as well as between males and females in the sex hormone receptors tested; androgen receptor (AR), progesterone receptor (PR), estrogen receptor alpha (ERα), and estrogen receptor beta (ERβ) using Western blot analysis. E1 and E3 stimulations in HCF females showed AR, PR, and ERβ were significantly upregulated compared to HCF males. In contrast, ERα and ERβ had significantly higher expression in HKC's females than HKC's males. Our data suggest that the human cornea is a sex-dependent, hormone-responsive tissue that is significantly influenced by E1 and E3. Therefore, it is plausible that E1, E3, and sex hormone receptors are involved in the KC pathobiology, warranting further investigation.

Citing Articles

Exploring New Links Among Keratoconus, Hormonal Factors, and Medications: Insights From a Case-Control Study Utilizing the All of Us Database.

Beatty C, Estes A, Xu H, Liu Y Transl Vis Sci Technol. 2024; 13(11):18.

PMID: 39556086 PMC: 11578156. DOI: 10.1167/tvst.13.11.18.


Ten-year incidence of keratoconus in relation to sex, age, and thyroid gland dysfunction: a nationwide population-based cohort study (2009-2018).

Chung I, Kim B, Han K, Yoo Y, Kim H, Jeong C Ann Transl Med. 2024; 12(3):45.

PMID: 38911561 PMC: 11193565. DOI: 10.21037/atm-23-1906.


Identification of hub genes and molecular pathways in keratoconus by integrating bioinformatics and literature mining at the RNA level.

Meng F, Ren S Int Ophthalmol. 2024; 44(1):244.

PMID: 38904678 DOI: 10.1007/s10792-024-03071-3.


Estrogen dysregulation, intraocular pressure, and glaucoma risk.

Youngblood H, Schoenlein P, Pasquale L, Stamer W, Liu Y Exp Eye Res. 2023; 237:109725.

PMID: 37956940 PMC: 10842791. DOI: 10.1016/j.exer.2023.109725.


Prospective Observational Study Evaluating Systemic Hormones and Corneal Crosslinking Effects in Keratoconus.

Van L, Bennett S, Nicholas S, Hjortdal J, McKay T, Karamichos D Ophthalmol Sci. 2023; 4(2):100364.

PMID: 37868794 PMC: 10585634. DOI: 10.1016/j.xops.2023.100364.


References
1.
Naderan M, Jahanrad A . Anterior, posterior and biomechanical parameters of cornea during pregnancy in healthy eyes: a cohort study. Br J Ophthalmol. 2017; 102(3):309-312. DOI: 10.1136/bjophthalmol-2017-310247. View

2.
Gordon-Shaag A, Millodot M, Shneor E, Liu Y . The genetic and environmental factors for keratoconus. Biomed Res Int. 2015; 2015:795738. PMC: 4449900. DOI: 10.1155/2015/795738. View

3.
Fink B, Sinnott L, Wagner H, Friedman C, Zadnik K . The influence of gender and hormone status on the severity and progression of keratoconus. Cornea. 2009; 29(1):65-72. DOI: 10.1097/ICO.0b013e3181ac0518. View

4.
Crescitelli M, Rauschemberger M, Cepeda S, Sandoval M, Massheimer V . Role of estrone on the regulation of osteoblastogenesis. Mol Cell Endocrinol. 2019; 498:110582. DOI: 10.1016/j.mce.2019.110582. View

5.
Vecsei P, Kircher K, Kaminski S, Nagel G, Breitenecker G, Kohlberger P . Immunohistochemical detection of estrogen and progesterone receptor in human cornea. Maturitas. 2000; 36(3):169-72. DOI: 10.1016/s0378-5122(00)00156-0. View